Treprostinil Palmitil Inhalation Powder trials for Hypertension

All Treprostinil Palmitil Inhalation Powder trials · All Hypertension trials

Phase breakdown

Recruiting trials studying Treprostinil Palmitil Inhalation Powder for Hypertension

• A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
  NCT07481981 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 20 locations
• An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07234032 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07179380 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 145 locations

Common questions

How many trials study Treprostinil Palmitil Inhalation Powder for Hypertension?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.